
Phoropter Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.

Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Phoropter Market size was valued at around USD 140.9 million in 2023 and is anticipated to grow a CAGR of 4.5% between 2024 and 2032. Phoropter is an instrument used in eye examinations to determine an individual's eyeglass prescription. It is an essential tool in optometry and ophthalmology diagnostics, allowing eye care professionals to measure refractive errors and prescribe corrective lenses accurately.

The increasing prevalence of eye disorder is a significant driver for the market. For instance, according to the World Health Organization (WHO), in 2023, globally, at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion of this vision impairment could have been prevented or is yet to be addressed. Thus, phoropters play a crucial role in accurately identifying these conditions, monitoring their progression, and prescribing corrective lenses to improve patients' vision and quality of life.
Furthermore, market growth is attributed to multiple factors, including the rising advancements in phoropter technology, increasing dry eye disease, which is estimated to reach 12.2 billion by 2032, rising demand for eye examinations, growing adoption of contact lenses and eyeglasses, and surging government initiatives.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2023 |
| Market Size in 2023 | USD 140.9 Million |
| Forecast Period 2024 – 2032 CAGR | 4.5% |
| Market Size in 2032 | USD 210.4 Million |
| Key Market Trends | |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Market expansion is anticipated to be propelled by the growing adoption of contact lenses and eyeglasses. These devices require specific prescriptions tailored to each individual's needs and phoropters ensure accuracy in these prescriptions.

Based on product type, the market is bifurcated into manual and automated. The automated segment held the market size of USD 100.3 million in 2023.

Based on end-use, the phoropter market is segmented into hospitals, specialty clinics, optical shops, and other end-users. The specialty clinics segment is expected reach a market size of USD 81.4 million by 2032.

North America phoropter market accounted for USD 57.1 million revenue in 2023 and is predicted to witness substantial market growth.
The phoropter industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. Companies are developing innovative phoropters to aid in disease diagnosis, prognosis, and treatment monitoring. These biomarkers range from manual to automated, reflecting the complex nature of various eye disorders. Regulatory approvals and collaborations with research institutions further influence market positioning.
Some of the eminent market participants operating in the phoropter industry include:
Market, By Product Type
Market, By End-use
The above information is provided for the following regions and countries:
Carl Zeiss Meditec AG, Huvitz Cor, Marco, NIDEK CO., LTD, Reichert, Inc., Rexxam Co, Ltd, Topcon Corporation, US Ophthalmic, Visionix, Xenon Ophthalmics Inc. are some of the major industry contenders.
North America phoropter industry accounted for USD 57.1 million in 2023 and is predicted to witness substantial growth through 2032, owing to a highly advanced healthcare infrastructure including high number of eye care facilities and specialty clinics in the region.
The Global phoropter industry was valued at around USD 140.9 million in 2023 and is estimated to reach over USD 210.4 million by 2032, owing to the increasing prevalence of eye disorder.
automated phoropter segment was remunerated at USD 100.3 million in 2023 and is set to gain traction by 2032, as they offer faster and more efficient refraction testing compared to manual phoropters.


